Literature DB >> 24030649

Change is in the air: the hypoxic induction of phenotype switching in melanoma.

Michael P O'Connell1, Ashani T Weeraratna2.   

Abstract

Melanoma cells can switch from a highly proliferative, less invasive state to a highly invasive, less proliferative state, a phenomenon termed phenotype switching. This results in a highly heterogenous tumor, where a slow-growing, aggressive population of cells may resist tumor therapy, and it predicts tumor recurrence. Here we discuss the observation made by Widmer et al. that hypoxia may drive phenotype switching.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24030649     DOI: 10.1038/jid.2013.208

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  9 in total

1.  Sleep Apnea and Cancer: Analysis of a Nationwide Population Sample.

Authors:  David Gozal; Sandra A Ham; Babak Mokhlesi
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

2.  Invadopodia-mediated ECM degradation is enhanced in the G1 phase of the cell cycle.

Authors:  Battuya Bayarmagnai; Louisiane Perrin; Kamyar Esmaeili Pourfarhangi; Xavier Graña; Erkan Tüzel; Bojana Gligorijevic
Journal:  J Cell Sci       Date:  2019-10-18       Impact factor: 5.285

3.  Acid Ceramidase in Melanoma: EXPRESSION, LOCALIZATION, AND EFFECTS OF PHARMACOLOGICAL INHIBITION.

Authors:  Natalia Realini; Francesca Palese; Daniela Pizzirani; Silvia Pontis; Abdul Basit; Anders Bach; Anand Ganesan; Daniele Piomelli
Journal:  J Biol Chem       Date:  2015-11-09       Impact factor: 5.157

4.  Ferroxitosis: a cell death from modulation of oxidative phosphorylation and PKM2-dependent glycolysis in melanoma.

Authors:  Alexander J Lakhter; James Hamilton; Pierre C Dagher; Suresh Mukkamala; Takashi Hato; X Charlie Dong; Lindsey D Mayo; Robert A Harris; Anantha Shekhar; Mircea Ivan; Nickolay Brustovetsky; Samisubbu R Naidu
Journal:  Oncotarget       Date:  2014-12-30

5.  Hypoxia drives the transition of human dermal fibroblasts to a myofibroblast-like phenotype via the TGF-β1/Smad3 pathway.

Authors:  Bin Zhao; Hao Guan; Jia-Qi Liu; Zhao Zheng; Qin Zhou; Jian Zhang; Lin-Lin Su; Da-Hai Hu
Journal:  Int J Mol Med       Date:  2016-12-01       Impact factor: 4.101

Review 6.  Understanding Keloid Pathobiology From a Quasi-Neoplastic Perspective: Less of a Scar and More of a Chronic Inflammatory Disease With Cancer-Like Tendencies.

Authors:  Silvian Tan; Nonhlanhla Khumalo; Ardeshir Bayat
Journal:  Front Immunol       Date:  2019-08-07       Impact factor: 7.561

Review 7.  Cellular Reprogramming-A Model for Melanoma Cellular Plasticity.

Authors:  Karol Granados; Juliane Poelchen; Daniel Novak; Jochen Utikal
Journal:  Int J Mol Sci       Date:  2020-11-05       Impact factor: 5.923

Review 8.  Understanding Molecular Mechanisms of Phenotype Switching and Crosstalk with TME to Reveal New Vulnerabilities of Melanoma.

Authors:  Ahmad Najem; Laura Soumoy; Malak Sabbah; Mohammad Krayem; Ahmad Awada; Fabrice Journe; Ghanem E Ghanem
Journal:  Cells       Date:  2022-03-29       Impact factor: 6.600

9.  Transition Therapy: Tackling the Ecology of Tumor Phenotypic Plasticity.

Authors:  Guim Aguadé-Gorgorió; Stuart Kauffman; Ricard Solé
Journal:  Bull Math Biol       Date:  2021-12-27       Impact factor: 1.758

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.